Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the following primary and secondary objectives in patients with moderate-to-severe Alzheimer’s disease (AD) and behavioral and psychiatric symptoms: Co-Primary Objectives • To evaluate the efficacy of Dimebon as compared to placebo on a measure of behavior, the Neuropsychiatric Inventory (NPI); • To evaluate the efficacy of Dimebon as compared to placebo on a measure of self-care and daily function, the Alzheimer’s Disease Cooperative Study – Activities of Daily Living (severe) (ADCS ADLsev).
Critère d'inclusion
- Alzheimer's disease